The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- HUYABIO International today announced the presentation of new patient data for HBI-3000, an antiarrhythmic drug (AAD) with a unique protective profile for the ...
Understanding a drug’s mechanism of action (MOA) can greatly increase the likelihood of successful clinical trials by identifying biomarkers of patient response and providing a rationale for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results